Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Ralston Shannon — Kiromic Biopharma, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Ralston Shannon

Ralston Shannon

10% owner at Kiromic Biopharma, Inc. · on record since May 22, 2024

Insider trading activity of Ralston Shannon

Transactions on record: 1; since Jun 4, 2024

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jun 4, 2024

Figures computed from official regulatory filings — methodology.

Companies where Ralston Shannon has traded

Kiromic Biopharma, Inc.1 tx · Jun 4, 2024

Track record of Ralston Shannon

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Ralston Shannon

Co-insiders of Ralston Shannon

BERSANI PIETROKiromic Biopharma, Inc.
Catlin MichaelKiromic Biopharma, Inc.
Chiriva Internati MaurizioKiromic Biopharma, Inc.
Cicchetti AmericoKiromic Biopharma, Inc.
Clark Daniel GrantKiromic Biopharma, Inc.
Dahlbeck ScottKiromic Biopharma, Inc.
Hungerford BrianKiromic Biopharma, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Mirandola LeonardoKiromic Biopharma, Inc.

Misajon PamelaKiromic Biopharma, Inc.

NAGEL MICHAELKiromic Biopharma, Inc.

Nunez IgnacioKiromic Biopharma, Inc.

Reeves KarenKiromic Biopharma, Inc.

Rotino GianlucaKiromic Biopharma, Inc.

Ryan Michael CharlesKiromic Biopharma, Inc.

Schneider Jerry A.Kiromic Biopharma, Inc.

Tirelli Francis XKiromic Biopharma, Inc.

Tontat TonyKiromic Biopharma, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Kiromic Biopharma, Inc.	Jun 4, 2024	BuyD	0	2,000,000.00 USD	$0	SEC